BR9808720A - Carprofeno seletivo para cox-2 para tratamento de dor e inflamação em cães - Google Patents
Carprofeno seletivo para cox-2 para tratamento de dor e inflamação em cãesInfo
- Publication number
- BR9808720A BR9808720A BR9808720-7A BR9808720A BR9808720A BR 9808720 A BR9808720 A BR 9808720A BR 9808720 A BR9808720 A BR 9808720A BR 9808720 A BR9808720 A BR 9808720A
- Authority
- BR
- Brazil
- Prior art keywords
- cox
- activity
- dogs
- acids
- carprofen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Patente de Invenção: <B>"CARPROFENO SELETIVO PARA COX-2 PARA TRATAMENTO DE DOR E INFLAMAçãO EM CãES"<D>. Tratamento ou prevenção de processos e doenças inflamatórios em cães associados com a atividade da ciclo-oxigenase-2 (COX-2) indutível, reduzindo ou eliminando ao mesmo tempo efeitos colaterais indesejáveis associados com a inibição simultânea da atividade da ciclooxigenase-1 (COX-1) constitutiva inibindo seletivamente a atividade de COX-2 em relação à atividade de COX-1, em que a razão de seletividade ou inibição da atividade de COX-2: COX-1 é de pelo menos 3 : 1 com base em níveis de inibição ex vivo medidos em sangue completo; o inibidor é um membro selecionado a partir do grupo de compostos antiinflamatórios que consiste essencialmente em derivados do ácido salicílico, derivados de p-aminofenol, ácido indol e indeno acéticos; ácidos heteroaril acéticos, ácidos arilpropiónicos, ácido antranílicos, ácidos enólicos e alcanonas; o inibidor em particular é constituído pelo enantiómero (+) (S) do ácido 6-cloro-<244>-metil-9H-carbazol-2-acético.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4563597P | 1997-05-05 | 1997-05-05 | |
| PCT/IB1998/000662 WO1998050033A1 (en) | 1997-05-05 | 1998-05-01 | Cox-2 selective carprofen for treating pain and inflammation in dogs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9808720A true BR9808720A (pt) | 2000-07-11 |
Family
ID=21939053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9808720-7A BR9808720A (pt) | 1997-05-05 | 1998-05-01 | Carprofeno seletivo para cox-2 para tratamento de dor e inflamação em cães |
Country Status (32)
| Country | Link |
|---|---|
| EP (1) | EP0988034A1 (pt) |
| JP (1) | JP2000513020A (pt) |
| KR (2) | KR20010012300A (pt) |
| CN (1) | CN1255059A (pt) |
| AP (1) | AP9801234A0 (pt) |
| AR (2) | AR011726A1 (pt) |
| AU (1) | AU6932198A (pt) |
| BG (1) | BG103852A (pt) |
| BR (1) | BR9808720A (pt) |
| CA (1) | CA2288759A1 (pt) |
| DZ (1) | DZ2479A1 (pt) |
| EA (1) | EA003696B1 (pt) |
| GT (1) | GT199800063A (pt) |
| HR (1) | HRP980244A2 (pt) |
| HU (1) | HUP0001286A3 (pt) |
| ID (1) | ID21311A (pt) |
| IL (1) | IL132570A0 (pt) |
| IS (1) | IS5220A (pt) |
| MA (1) | MA26491A1 (pt) |
| NO (1) | NO995389L (pt) |
| NZ (1) | NZ500183A (pt) |
| OA (1) | OA11213A (pt) |
| PA (1) | PA8450601A1 (pt) |
| PE (1) | PE72599A1 (pt) |
| PL (1) | PL337003A1 (pt) |
| SK (1) | SK148199A3 (pt) |
| TN (1) | TNSN98059A1 (pt) |
| TW (1) | TW590773B (pt) |
| UY (1) | UY24989A1 (pt) |
| WO (1) | WO1998050033A1 (pt) |
| YU (1) | YU55899A (pt) |
| ZA (1) | ZA983722B (pt) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6245797B1 (en) | 1997-10-22 | 2001-06-12 | Merck & Co., Inc. | Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease |
| AU2003204888B2 (en) * | 1998-05-22 | 2005-07-28 | Pfizer Products Inc. | Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives |
| US6506785B2 (en) | 1998-05-22 | 2003-01-14 | Pfizer, Inc. | Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives |
| AU764872B2 (en) * | 1998-10-23 | 2003-09-04 | Merck Frosst Canada & Co. | Combination product comprising an E-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use |
| CA2363590A1 (en) * | 1999-03-10 | 2000-09-14 | G.D. Searle & Co. | Method and composition for administering a cyclooxygenase-2 inhibitor |
| WO2001034204A1 (en) * | 1999-11-11 | 2001-05-17 | Eli Lilly And Company | Oncolytic combinations for the treatment of cancer |
| EP1283723A2 (en) * | 2000-05-15 | 2003-02-19 | Merck Frosst Canada & Co. | Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor |
| RU2003100874A (ru) | 2000-06-13 | 2004-06-27 | Вайс (Us) | Болеутоляющие и противовоспалительные составы, содержащие ингибиторы циклооксигеназы-2 |
| DE10032132A1 (de) * | 2000-07-01 | 2002-01-17 | Lohmann Therapie Syst Lts | Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung |
| DE60137512D1 (de) | 2000-08-07 | 2009-03-12 | Univ Vanderbilt | Zusammensetzungen und verfahren zum nachweis und zur quantifizierung von cox-2-aktivität und 2-arachidonylglycerin-metaboliten |
| US20040209959A1 (en) * | 2001-07-16 | 2004-10-21 | Edward Hogestatt | Congeners of acetaminophen and related compounds as substrates for fatty acid conjugation and their use in treatment of pain, fever and inflammation |
| DK1534305T3 (da) | 2003-05-07 | 2007-02-05 | Osteologix As | Behandling af brusk-/knoglelidelser med vandoplöselige strontiumsalte |
| MXPA06001288A (es) * | 2003-07-31 | 2006-04-11 | Upjohn Co | Formulacion dispersable de un agente anti-inflamatorio. |
| AU2006248645A1 (en) * | 2005-05-20 | 2006-11-23 | Pfizer Limited | Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-delta-ligands |
| CN103120653B (zh) | 2007-04-04 | 2015-09-30 | 希格默伊德药业有限公司 | 一种口服药物组合物 |
| CA2942083C (en) | 2007-04-26 | 2019-01-29 | Sigmoid Pharma Limited | Manufacture of multiple minicapsules |
| SG176145A1 (en) | 2009-05-18 | 2011-12-29 | Sigmoid Pharma Ltd | Composition comprising oil drops |
| JP5911799B2 (ja) | 2009-08-12 | 2016-04-27 | シグモイド・ファーマ・リミテッドＳｉｇｍｏｉｄ Ｐｈａｒｍａ Ｌｉｍｉｔｅｄ | ポリマーマトリックスおよび油相を含んで成る免疫調節組成物 |
| GB201020032D0 (en) | 2010-11-25 | 2011-01-12 | Sigmoid Pharma Ltd | Composition |
| GB201212010D0 (en) | 2012-07-05 | 2012-08-22 | Sigmoid Pharma Ltd | Formulations |
| GB201319791D0 (en) | 2013-11-08 | 2013-12-25 | Sigmoid Pharma Ltd | Formulations |
| DK3113774T3 (da) | 2014-03-06 | 2022-03-07 | Elanco Animal Health Incorporated | Sammensætninger af grapiprant og fremgangsmåder til anvendelse deraf |
| PL3215127T3 (pl) | 2014-11-07 | 2021-05-17 | Sublimity Therapeutics Limited | Kompozycje zawierające cyklosporynę |
| US12109218B2 (en) | 2014-12-09 | 2024-10-08 | Aratana Therapeutics, Inc. | Compositions of grapiprant and methods for using the same |
| AU2016205145A1 (en) * | 2015-01-09 | 2017-07-13 | Jaguar Health, Inc. | Methods of treating diarrhea in companion animals |
| WO2021195346A1 (en) * | 2020-03-25 | 2021-09-30 | Sri International | Lipoxygenase inhibitors |
| US11116737B1 (en) | 2020-04-10 | 2021-09-14 | University Of Georgia Research Foundation, Inc. | Methods of using probenecid for treatment of coronavirus infections |
| KR102404883B1 (ko) | 2020-11-30 | 2022-06-07 | (주)이노보테라퓨틱스 | 벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3896145A (en) * | 1972-07-24 | 1975-07-22 | Hoffmann La Roche | Carbazoles |
| CA1319886C (en) * | 1987-02-03 | 1993-07-06 | Alberto Ferro | Mixed micelle solutions |
-
1998
- 1998-03-02 DZ DZ980089A patent/DZ2479A1/xx active
- 1998-04-30 TW TW087106689A patent/TW590773B/zh not_active IP Right Cessation
- 1998-05-01 CA CA002288759A patent/CA2288759A1/en not_active Abandoned
- 1998-05-01 AU AU69321/98A patent/AU6932198A/en not_active Abandoned
- 1998-05-01 WO PCT/IB1998/000662 patent/WO1998050033A1/en not_active Application Discontinuation
- 1998-05-01 SK SK1481-99A patent/SK148199A3/sk unknown
- 1998-05-01 KR KR1019997010252A patent/KR20010012300A/ko not_active Application Discontinuation
- 1998-05-01 YU YU55899A patent/YU55899A/sh unknown
- 1998-05-01 HU HU0001286A patent/HUP0001286A3/hu unknown
- 1998-05-01 EP EP98915041A patent/EP0988034A1/en not_active Withdrawn
- 1998-05-01 NZ NZ500183A patent/NZ500183A/en unknown
- 1998-05-01 PL PL98337003A patent/PL337003A1/xx unknown
- 1998-05-01 JP JP10547869A patent/JP2000513020A/ja active Pending
- 1998-05-01 EA EA199900895A patent/EA003696B1/ru not_active IP Right Cessation
- 1998-05-01 IL IL13257098A patent/IL132570A0/xx unknown
- 1998-05-01 ID IDP980651A patent/ID21311A/id unknown
- 1998-05-01 CN CN98804845A patent/CN1255059A/zh active Pending
- 1998-05-01 KR KR10-2003-7005258A patent/KR20040004406A/ko not_active Application Discontinuation
- 1998-05-01 BR BR9808720-7A patent/BR9808720A/pt not_active IP Right Cessation
- 1998-05-04 AP APAP/P/1998/001234A patent/AP9801234A0/en unknown
- 1998-05-04 UY UY24989A patent/UY24989A1/es not_active Application Discontinuation
- 1998-05-04 PE PE1998000335A patent/PE72599A1/es not_active Application Discontinuation
- 1998-05-04 TN TNTNSN98059A patent/TNSN98059A1/fr unknown
- 1998-05-04 GT GT199800063A patent/GT199800063A/es unknown
- 1998-05-04 MA MA25059A patent/MA26491A1/fr unknown
- 1998-05-04 ZA ZA9803722A patent/ZA983722B/xx unknown
- 1998-05-05 HR HR60/045,635A patent/HRP980244A2/hr not_active Application Discontinuation
- 1998-05-05 AR ARP980102089A patent/AR011726A1/es unknown
- 1998-05-05 PA PA19988450601A patent/PA8450601A1/es unknown
-
1999
- 1999-10-19 IS IS5220A patent/IS5220A/is unknown
- 1999-11-02 OA OA9900242A patent/OA11213A/en unknown
- 1999-11-03 BG BG103852A patent/BG103852A/xx unknown
- 1999-11-04 NO NO995389A patent/NO995389L/no not_active Application Discontinuation
-
2003
- 2003-04-09 AR ARP030101251A patent/AR039628A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9808720A (pt) | Carprofeno seletivo para cox-2 para tratamento de dor e inflamação em cães | |
| Jayanthi et al. | Methamphetamine downregulates striatal glutamate receptors via diverse epigenetic mechanisms | |
| Kolbe et al. | 4‐n‐butylresorcinol, a highly effective tyrosinase inhibitor for the topical treatment of hyperpigmentation | |
| SE9603408D0 (sv) | Medical use | |
| CY1107729T1 (el) | Φαρμακευτικες συνθεσεις | |
| ATE527022T1 (de) | Verwendung von cyclooxygenase-2-inhibitoren zur behandlung und vorbeugung von tumoren, von tumor- abhängigen erkrankungen und kachexie | |
| NO963568D0 (no) | Farmasöytisk preparat for behandling av blodkoagulasjonssykdommer, fremgangsmåter for fremstilling av dette og dets anvendelse | |
| PT944631E (pt) | Novos derivados substituidos de pirazole para tratamento de doencas cardiovasculares | |
| EA200200246A1 (ru) | Композиция, содержащая нестероидное противовоспалительное средство (nsaid) и ингибитор киназы egfr, для лечения или ингибирования полипов в ободочной кишке и рака ободочной и прямой кишки | |
| ATE369848T1 (de) | Verwendung von d-serine oder d-alanine zur behandlung von schizophrenie | |
| BR9814147A (pt) | "derivados de ácido carboxìlico e hidroxâmico tendo atividade inibitória de mmp e tnf" | |
| WO2000028980A3 (en) | Combination of duloxetine with non-steroidal antiinflammatory drug for treating pain | |
| BR0011172A (pt) | Derivados do 4,5-diaril-3(2h)-furanona como inibidores de cliclooxigenase-2 | |
| BR0206381A (pt) | Derivados do ácido fumárico como inibidor de nf-kappab | |
| PT1039895E (pt) | Utilizacao de acidos 3-benzoilfenilaceticos respectivos esteres ou amidas para o tratamento do glaucoma glc1a | |
| ATE357438T1 (de) | 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems | |
| CY1106155T1 (el) | Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους | |
| PT1005460E (pt) | Biossintese de inibidores de prostaglandina-endoperoxido h-sintase | |
| BR9910539A (pt) | Derivados de 2 - (2 - clorofenil) - 3,4 - dihidro - 2h - pirrol | |
| Ventura-Martínez et al. | Peripheral involvement of the nitric oxide–cGMP pathway in the indomethacin-induced antinociception in rat | |
| Jain et al. | Analgesic, anti‐inflammatory and ulcerogenic activity of a zinc‐naproxen complex in mice and rats | |
| DK1154766T3 (da) | Anvendelse af R-arylpropionsyre til fremstilling af lægemidler til behandling af sygdomme hos mennesker og dyr, hvor sygdommene kan påvirkes terapeutisk ved inhibering af aktiveringen af NF-kappa B | |
| ATE345123T1 (de) | Behandlung von angiogenesebezogenen krankheiten mit benzoyl phenylessigsäure derivaten | |
| HUP0400886A2 (hu) | Koleszteril-észter transzfer protein inhibitorok és fibrinsav-származékok kombinációi szív-érrendszeri indikációkhoz | |
| HUP0300689A2 (hu) | Eljárás és kompozíciók gyulladásos betegségek kezelésére |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A E 9A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1908 DE 31/07/2007. |